Hybrid coronary revascularization is an emerging alternative to standard surgical or catheter-based techniques, though it currently lacks randomized clinical trial data.
Without RCT data, hybrid revascularization should not enter routine practice; leaves open its comparative role pending prospective trials.
A hybrid strategy is a combination of catheter-based therapy and traditional surgical intervention.This concept of combining the tools available only in the catheterization laboratory with the tools available only to the surgeon in order to minimize surgical morbidity has evolved since its implementation in the 1990s. 1 Over the past decade, with advancement in stent technology and refinement of minimally invasive surgical approaches, a hybrid strategy has become an attractive alternative to standard surgical or catheter-based techniques.The indications, patient selection, and standardization of these procedures are still under way.Currently, there are no randomized clinical trials on hybrid procedures, and the clinical practice is based on single institutional experiences.The National Heart, Lung, and Blood Institute has just launched the first observational trial on hybrid coronary intervention to define the population eligible for hybrid coronary revascularization (HCR).Until more data become available, the hybrid strategy depends on close collaboration between the surgeon and the cardiologist at single institutions and should be tailored to individual patient needs.
No takes yet. Share an insight, caveat, or question.
Leacche et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: